Gerresheimer

Gerresheimer’s Accounting Storm Tests Investor Trust Despite Strong Pharma Tailwinds

kashif hafeez - June 19, 2026

Gerresheimer’s 50% Surge Belies a Minefield of Leasing Errors, BaFin Probes, and a Delayed Audit

Brett Shapiro - May 14, 2026

Gerresheimer Insider Spends Millions on Stock as Creditor Reprieve Fuels Speculative Rally

kashif hafeez - May 8, 2026

Gerresheimer’s Creditor Reprieve Buys Time for a Centor Sale — but the Accounting Cloud Won’t Lift Until June

angelina - April 30, 2026

Gerresheimer’s Share Price Recovery Masks a Deepening Legal and Financial Crisis

April 27, 2026

Gerresheimer’s Countdown to June: Audited Accounts Are the Only Cure

angelina - April 26, 2026

Gerresheimer Faces a Defining June as Creditors Grant Breathing Room

April 25, 2026

Gerresheimer’s Accounting Scandal Deepens as Regulators Close In on KPMG

April 24, 2026

Gerresheimer Navigates a Cost Crunch and Corporate Overhaul

kashif hafeez - April 20, 2026

Gerresheimer’s Crisis Deepens as Auditor Faces Regulatory Probe

Brett Shapiro - April 15, 2026

Gerresheimer’s Creditors and a Clock Ticking to June

Brett Shapiro - April 13, 2026

Gerresheimer’s Accounting Crisis Deepens with Auditor Scrutiny and Legal Threats

April 7, 2026

Gerresheimer Faces Mounting Scrutiny as Accounting Crisis Deepens

Brett Shapiro - March 16, 2026

Regulatory Scrutiny Intensifies for Gerresheimer

angelina - February 28, 2026